Liver transplantation in patients with non-alcoholic steatohepatitis and alcohol-related liver disease: the dust is yet to settle.
作者信息
Satapathy Sanjaya K, Bernstein David E, Roth Nitzan C
机构信息
Division of Hepatology at Sandra Atlas Bass Center for Liver Diseases & Transplantation, Manhasset, NY, USA.
Department of Medicine, Barbara and Zucker School of Medicine/Northwell Health, Manhasset, NY, USA.
出版信息
Transl Gastroenterol Hepatol. 2022 Jul 25;7:23. doi: 10.21037/tgh-2020-15. eCollection 2022.
Abstract
摘要
相似文献
1
Liver transplantation in patients with non-alcoholic steatohepatitis and alcohol-related liver disease: the dust is yet to settle.非酒精性脂肪性肝炎和酒精性肝病患者的肝移植：尘埃尚未落定。
Transl Gastroenterol Hepatol. 2022 Jul 25;7:23. doi: 10.21037/tgh-2020-15. eCollection 2022.
2
Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.影响脂肪性肝炎中肝细胞癌的代谢因素。
Liver Int. 2019 Mar;39(3):531-539. doi: 10.1111/liv.14002. Epub 2018 Dec 2.
3
Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation.原位肝移植后复发性和新发非酒精性脂肪性肝炎
Arq Gastroenterol. 2001 Oct-Dec;38(4):247-53. doi: 10.1590/s0004-28032001000400007.
4
Both alcoholic and non-alcoholic steatohepatitis association with cardiovascular risk and liver fibrosis.酒精性和非酒精性脂肪性肝炎均与心血管风险和肝纤维化相关。
Alcohol. 2018 Jun;69:63-67. doi: 10.1016/j.alcohol.2017.11.004. Epub 2017 Nov 15.
5
Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis.反式脂肪和酒精的添加对脂肪性肝炎的啮齿动物模型的动脉粥样硬化饮食诱导的肝损伤有不同的影响。
Am J Physiol Gastrointest Liver Physiol. 2020 Mar 1;318(3):G410-G418. doi: 10.1152/ajpgi.00066.2019. Epub 2020 Jan 6.
6
Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitis.血清镁浓度与非酒精性脂肪肝和非酒精性脂肪性肝炎独立相关。
United European Gastroenterol J. 2018 Feb;6(1):97-103. doi: 10.1177/2050640617707863. Epub 2017 Apr 25.
7
Histopathology of Alcohol-Related Liver Diseases.酒精性肝病的组织病理学。
Clin Liver Dis. 2019 Feb;23(1):11-23. doi: 10.1016/j.cld.2018.09.001.
8
Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study.非酒精性脂肪性肝炎患者血浆转化生长因子-β1水平及α-生育酚的疗效：一项初步研究
Aliment Pharmacol Ther. 2001 Oct;15(10):1667-72. doi: 10.1046/j.1365-2036.2001.01083.x.
10
PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.聚腺苷二磷酸核糖聚合酶抑制剂可预防酒精性和非酒精性脂肪性肝炎。
J Hepatol. 2017 Mar;66(3):589-600. doi: 10.1016/j.jhep.2016.10.023. Epub 2016 Oct 29.
引用本文的文献
1
Long-Term Feasibility and Outcomes of a Digital Health Program to Improve Liver Fat and Cardiometabolic Markers in Individuals With Nonalcoholic Fatty Liver Disease: Prospective Single-Arm Feasibility Study.一项改善非酒精性脂肪性肝病患者肝脏脂肪和心脏代谢指标的数字健康计划的长期可行性及结果：前瞻性单臂可行性研究
JMIR Cardio. 2025 Sep 12;9:e72074. doi: 10.2196/72074.
2
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information.利用常规临床信息的机器学习方法增强 MASLD 患者的诊断和分期。
PLoS One. 2024 Feb 29;19(2):e0299487. doi: 10.1371/journal.pone.0299487. eCollection 2024.
3
Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study.抗载脂蛋白A1抗体、非酒精性脂肪性肝病与心血管风险：一项转化研究。
J Transl Med. 2023 Oct 5;21(1):694. doi: 10.1186/s12967-023-04569-7.
4
Collagen matrix scaffolds: Future perspectives for the management of chronic liver diseases.胶原蛋白基质支架：慢性肝病治疗的未来展望。
World J Clin Cases. 2023 Feb 26;11(6):1224-1235. doi: 10.12998/wjcc.v11.i6.1224.
本文引用的文献
1
Bariatric surgery, obesity and liver transplantation.减重手术、肥胖症与肝移植
Transl Gastroenterol Hepatol. 2022 Jul 25;7:25. doi: 10.21037/tgh-2020-14. eCollection 2022.
2
Implications of pre-transplant sarcopenia and frailty in patients with non-alcoholic steatohepatitis and alcoholic liver disease.非酒精性脂肪性肝炎和酒精性肝病患者移植前肌肉减少症和虚弱的影响
Transl Gastroenterol Hepatol. 2022 Jul 25;7:29. doi: 10.21037/tgh-20-236. eCollection 2022.
3
Multimodal multidisciplinary management of alcohol use disorder in liver transplant candidates and recipients.肝移植候选者和受者酒精使用障碍的多模式多学科管理
Transl Gastroenterol Hepatol. 2022 Jul 25;7:28. doi: 10.21037/tgh.2020.02.22. eCollection 2022.
4
Pre-transplant portal vein thrombosis in non-alcoholic fatty liver disease patients-pathogenesis, risk factors, and implications on management.非酒精性脂肪性肝病患者移植前门静脉血栓形成——发病机制、危险因素及对治疗的影响
Transl Gastroenterol Hepatol. 2022 Jul 25;7:27. doi: 10.21037/tgh-19-361. eCollection 2022.
5
Metabolic syndrome following liver transplantation in nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者肝移植后的代谢综合征
Transl Gastroenterol Hepatol. 2021 Jan 5;6:13. doi: 10.21037/tgh.2020.02.07. eCollection 2021.
6
Acute on Chronic Liver Failure From Nonalcoholic Fatty Liver Disease: A Growing and Aging Cohort With Rising Mortality.非酒精性脂肪性肝病相关慢加急性肝衰竭：发病率和病死率均升高的老年患者群体
Hepatology. 2021 May;73(5):1932-1944. doi: 10.1002/hep.31566. Epub 2021 Mar 25.
7
Acute-on-chronic liver failure in liver transplant candidates with non-alcoholic steatohepatitis.非酒精性脂肪性肝炎所致肝移植候选者的慢加急性肝衰竭
Transl Gastroenterol Hepatol. 2020 Jul 5;5:38. doi: 10.21037/tgh.2019.10.01. eCollection 2020.
8
Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.非酒精性脂肪性肝病的发病机制及其对肝移植心血管结局的影响
Transl Gastroenterol Hepatol. 2020 Jul 5;5:36. doi: 10.21037/tgh.2019.12.02. eCollection 2020.
9
Post-transplant malignancies in alcoholic liver disease.酒精性肝病中的移植后恶性肿瘤
Transl Gastroenterol Hepatol. 2020 Apr 5;5:30. doi: 10.21037/tgh.2019.11.18. eCollection 2020.
10
Liver transplantation for alcoholic hepatitis.酒精性肝炎的肝移植
Transl Gastroenterol Hepatol. 2020 Apr 5;5:26. doi: 10.21037/tgh.2019.11.17. eCollection 2020.
Zotero 插件